Skip to main content
Premium Trial:

Request an Annual Quote

Tisch Cancer Institute Receives NCI Cancer Center Designation

NEW YORK (GenomeWeb) – The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has been named a National Cancer Institute cancer center, Mount Sinai said today.

"The NCI designation recognizes our deep commitment to advance the field of cancer research, treatment, and prevention, and to bring these innovations to cancer patients and their families," TCI Director Steven Burakoff said in a statement. "The designation reflects Mount Sinai's significant investment in cancer research, world-class faculty, and cutting-edge facilities."

The designation includes a five-year, $8.5 million grant, which will be used to support research programs, facilitate researcher recruitment, and to improve community engagement, Mount Sinai said.

Mount Sinai President and CEO Kenneth Davis noted that among the institute's strengths that were "central to our NCI designation" was TCI's research, based on New York's diverse ethnic communities, into the genetic differences and disparities in care that result in greater cancer risk for some patients.